Literature DB >> 23217540

Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse.

Christina S Kong1, Hongbin Cao, Shirley Kwok, Catherine M Nguyen, Richard C Jordan, Veronica G Beaudry, Laura D Attardi, Quynh-Thu Le.   

Abstract

BACKGROUND: PERP is a p53/p63-regulated gene encoding a desmosomal protein that plays a critical role in cell-cell adhesion and tumor suppression. STUDY
DESIGN: We evaluated PERP expression in different grades of oral dysplasia (34 cases) and at different stages of invasive squamous cell carcinoma (SCC), and correlated the latter with clinical outcome. A tissue microarray consisting of nondysplastic mucosa, carcinoma in situ, SCC, and nodal metastases from 33 patients with human papilloma virus-negative SCC was stained for PERP and E-cadherin.
RESULTS: Complete loss of PERP expression was associated with worse local control in patients with SCC. The 5-year local control rate was 91% for patients with partial PERP loss versus 31% for those with complete loss (P = .01).
CONCLUSIONS: This is the first study to show that loss of PERP expression correlates with the transition to SCC and with increased local relapse in patients with oral cavity SCC.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23217540      PMCID: PMC3523282          DOI: 10.1016/j.oooo.2012.10.017

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  23 in total

Review 1.  Head and neck cancer.

Authors:  A Forastiere; W Koch; A Trotti; D Sidransky
Journal:  N Engl J Med       Date:  2001-12-27       Impact factor: 91.245

2.  Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays.

Authors:  Chih Long Liu; Wijan Prapong; Yasodha Natkunam; Ash Alizadeh; Kelli Montgomery; C Blake Gilks; Matt van de Rijn
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Observer agreement in the grading of oral epithelial dysplasia.

Authors:  D J Brothwell; D W Lewis; G Bradley; I Leong; R C K Jordan; D Mock; J L Leake
Journal:  Community Dent Oral Epidemiol       Date:  2003-08       Impact factor: 3.383

4.  Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients.

Authors:  Hongbin Cao; Alice Banh; Shirley Kwok; Xiaoli Shi; Simon Wu; Trevor Krakow; Brian Khong; Brindha Bavan; Rajeev Bala; Benjamin A Pinsky; Dimitrios Colevas; Nader Pourmand; Albert C Koong; Christina S Kong; Quynh-Thu Le
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-10-08       Impact factor: 7.038

5.  PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family.

Authors:  L D Attardi; E E Reczek; C Cosmas; E G Demicco; M E McCurrach; S W Lowe; T Jacks
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

6.  A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma.

Authors:  V Chow; A P Yuen; K Y Lam; G S Tsao; W K Ho; W I Wei
Journal:  J Cancer Res Clin Oncol       Date:  2001-01       Impact factor: 4.553

7.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Authors:  M L Gillison; W M Koch; R B Capone; M Spafford; W H Westra; L Wu; M L Zahurak; R W Daniel; M Viglione; D E Symer; K V Shah; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

8.  Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis.

Authors:  Veronica G Beaudry; Dadi Jiang; Rachel L Dusek; Eunice J Park; Stevan Knezevich; Katie Ridd; Hannes Vogel; Boris C Bastian; Laura D Attardi
Journal:  PLoS Genet       Date:  2010-10-21       Impact factor: 5.917

9.  Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer.

Authors:  Rachel L Dusek; Jamie L Bascom; Hannes Vogel; Sylvain Baron; Alexander D Borowsky; Mina J Bissell; Laura D Attardi
Journal:  Breast Cancer Res       Date:  2012-04-20       Impact factor: 6.466

10.  Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx.

Authors:  Gerhard F Huber; Lena Züllig; Alex Soltermann; Matthias Roessle; Nicole Graf; Stephan K Haerle; Gabriela Studer; Wolfram Jochum; Holger Moch; Sandro J Stoeckli
Journal:  BMC Cancer       Date:  2011-06-03       Impact factor: 4.430

View more
  7 in total

1.  ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells.

Authors:  I A Khan; B H Yoo; O Masson; S Baron; D Corkery; G Dellaire; L D Attardi; K V Rosen
Journal:  Oncogene       Date:  2016-04-25       Impact factor: 9.867

2.  SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.

Authors:  Hiroyuki Ozawa; Ruchira S Ranaweera; Evgeny Izumchenko; Eugene Makarev; Alex Zhavoronkov; Elana J Fertig; Jason D Howard; Ana Markovic; Atul Bedi; Rajani Ravi; Jimena Perez; Quynh-Thu Le; Christina S Kong; Richard C Jordan; Hao Wang; Hyunseok Kang; Harry Quon; David Sidransky; Christine H Chung
Journal:  Clin Cancer Res       Date:  2017-05-18       Impact factor: 12.531

Review 3.  Desmosomes in acquired disease.

Authors:  Sara N Stahley; Andrew P Kowalczyk
Journal:  Cell Tissue Res       Date:  2015-03-21       Impact factor: 5.249

4.  Cancer Stem Cells: Emergent Nature of Tumor Emergency.

Authors:  Yaroslav R Efremov; Anastasia S Proskurina; Ekaterina A Potter; Evgenia V Dolgova; Oksana V Efremova; Oleg S Taranov; Aleksandr A Ostanin; Elena R Chernykh; Nikolay A Kolchanov; Sergey S Bogachev
Journal:  Front Genet       Date:  2018-11-16       Impact factor: 4.599

5.  DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression.

Authors:  Bao-Qian Shan; Xiao-Min Wang; Li Zheng; Yao Han; Jie Gao; Meng-Dan Lv; Yi Zhang; Yi-Xuan Liu; Han Zhang; Hao-Sa Chen; Lei Ao; Yin-Li Zhang; Xiang Lu; Zhong-Jie Wu; Ying Xu; Xuan Che; Michal Heger; Shu-Qun Cheng; Wei-Wei Pan; Xin Zhang
Journal:  Cancer Sci       Date:  2022-03-18       Impact factor: 6.518

Review 6.  The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.

Authors:  Xiaoge Hu; Xiangxiang Lei; Jinhui Guo; Wen Fu; Wen Sun; Qiliang Lu; Wei Su; Qiuran Xu; Kangsheng Tu
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

7.  Conditional deletion of Ahr alters gene expression profiles in hematopoietic stem cells.

Authors:  John A Bennett; Kameshwar P Singh; Stephen L Welle; Lisbeth A Boule; B Paige Lawrence; Thomas A Gasiewicz
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.